Lungenkrebstherapeutika Marktgröße, Anteil und Branchenanalyse nach Therapie (gezielte Therapie, Immuntherapie, Chemotherapie), nach Krebstyp (nicht-kleinzelliger Lungenkrebs (NSCLC), kleinzelliger Lungenkrebs (SCLC)), nach Vertriebskanal (Krankenhaus Apotheken, Präsenzapotheken, Online-Apotheken) und Regionalprognose 2019-2026

Letzte Aktualisierung: October 21, 2024 | Format: PDF | Bericht-ID: FBI100473

MARKTSEGMENTIERUNG:

Um Informationen zu verschiedenen Segmenten zu erhalten, teilen Sie uns Ihre Fragen mit

SEGMENTIERUNG

DETAILS

Durch Therapie

· Gezielte Therapie

· Bevacizumab

· Dabrafenib/Trametinib

· Erlotinib-Hydrochlorid

· Osimertinib

· Andere

· Immuntherapie

· Durvalumab

· Nivolumab

· Atezolizumab

· Pembrolizumab

· Chemotherapie

Nach Krebstyp

· Nicht-kleinzelliger Lungenkrebs (NSCLC)

· Kleinzelliger Lungenkrebs (SCLC)

Nach Vertriebskanal

· Krankenhausapotheken

· Einzelhandelsapotheken

· Online-Apotheken

· Andere

Nach Geografie

· Nordamerika (USA und Kanada)

· Europa (Deutschland, Großbritannien, Frankreich, Italien, Spanien, Skandinavien und übriges Europa)

· Asien-Pazifik (China, Indien, Japan, Australien, Südostasien und der übrige asiatisch-pazifische Raum)

· Lateinamerika (Brasilien, Mexiko und der Rest Lateinamerikas)

· Naher Osten und Afrika (GCC, Südafrika und Rest des Nahen Ostens und Afrikas)

BERICHT AKTUALISIEREN
IN VERFAHREN
STUDIE ZEITRAUM: 2019-2032
(In Verfahren)
BASE JAHR:2023
(In Verfahren)

Gesundheitswesen Kunden

Verwandte Berichte

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry

Nehmen Sie Kontakt mit uns auf

+1 833 909 2966 ( Toll Free )(US)
+44 808 502 0280 ( Toll Free )(UK)

+91 744 740 1245 (APAC)
[email protected]